237 related articles for article (PubMed ID: 22491734)
1. An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergencies.
Khorsand N; Veeger NJ; van Hest RM; Ypma PF; Heidt J; Meijer K
Haematologica; 2012 Oct; 97(10):1501-6. PubMed ID: 22491734
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
Sarode R; Milling TJ; Refaai MA; Mangione A; Schneider A; Durn BL; Goldstein JN
Circulation; 2013 Sep; 128(11):1234-43. PubMed ID: 23935011
[TBL] [Abstract][Full Text] [Related]
3. Fixed Versus Variable Dosing of Prothrombin Complex Concentrate for Bleeding Complications of Vitamin K Antagonists-The PROPER3 Randomized Clinical Trial.
Abdoellakhan RA; Khorsand N; Ter Avest E; Lameijer H; Faber LM; Ypma PF; Nieuwenhuizen L; Veeger NJGM; Meijer K
Ann Emerg Med; 2022 Jan; 79(1):20-30. PubMed ID: 34535300
[TBL] [Abstract][Full Text] [Related]
4. Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy.
Khorsand N; Veeger NJ; Muller M; Overdiek JW; Huisman W; van Hest RM; Meijer K
Transfus Med; 2011 Apr; 21(2):116-23. PubMed ID: 21073580
[TBL] [Abstract][Full Text] [Related]
5. Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis.
Abdoellakhan RA; Miah IP; Khorsand N; Meijer K; Jellema K
Neurocrit Care; 2017 Feb; 26(1):64-69. PubMed ID: 27052728
[TBL] [Abstract][Full Text] [Related]
6. Randomised controlled trial protocol to evaluate a fixed dose prothrombin complex concentrate against the variable dose in vitamin K antagonist related bleeding (PROPER3).
Abdoellakhan RA; Khorsand N; Van Hest RM; Veeger N; Ter Avest E; Ypma PF; Faber LM; Meijer K
BMJ Open; 2018 Mar; 8(3):e020764. PubMed ID: 29540424
[TBL] [Abstract][Full Text] [Related]
7. Prospective Evaluation of a Fixed-Dose 4-Factor Prothrombin Complex Concentrate Protocol for Urgent Vitamin K Antagonist Reversal.
Bitonti MT; Rumbarger RL; Absher RK; Curran LM
J Emerg Med; 2020 Feb; 58(2):324-329. PubMed ID: 31787372
[TBL] [Abstract][Full Text] [Related]
8. Activated Prothrombin Complex Concentrate Versus 4-Factor Prothrombin Complex Concentrate for Vitamin K-Antagonist Reversal.
Rowe AS; Dietrich SK; Phillips JW; Foster KE; Canter JR
Crit Care Med; 2018 Jun; 46(6):943-948. PubMed ID: 29498942
[TBL] [Abstract][Full Text] [Related]
9. Fixed- versus variable-dose prothrombin complex concentrate protocol for vitamin K antagonist reversal.
Bizzell AC; Mousavi MK; Yin E
Int J Hematol; 2021 Sep; 114(3):334-341. PubMed ID: 34191234
[TBL] [Abstract][Full Text] [Related]
10. Weight-Based Dosing Versus a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate in Obese Patients Requiring Vitamin K Antagonist Reversal.
Elsamadisi P; Cepeda MAG; Yankama T; Wong A; Tran Q; Eche IM
Am J Cardiovasc Drugs; 2021 May; 21(3):355-361. PubMed ID: 33150496
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of fixed versus variable dosing of 4-factor prothrombin complex concentrate for emergent warfarin reversal.
Stoecker Z; Van Amber B; Woster C; Isenberger K; Peterson M; Rupp P; Chrenka E; Dries D
Am J Emerg Med; 2021 Oct; 48():282-287. PubMed ID: 34022636
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of prothrombin complex concentrate dosing strategies to reverse vitamin K antagonist therapy.
Khorsand N; Kooistra HA; van Hest RM; Veeger NJ; Meijer K
Thromb Res; 2015 Jan; 135(1):9-19. PubMed ID: 25480313
[TBL] [Abstract][Full Text] [Related]
13. Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice.
Desmettre T; Dehours E; Samama CM; Jhundoo S; Pujeau F; Guillaudin C; Hecquart C; Clerson P; Crave JC; Jaussaud R
Crit Care; 2012 Oct; 16(5):R185. PubMed ID: 23036234
[TBL] [Abstract][Full Text] [Related]
14. Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding.
Schick KS; Fertmann JM; Jauch KW; Hoffmann JN
Crit Care; 2009; 13(6):R191. PubMed ID: 19948037
[TBL] [Abstract][Full Text] [Related]
15. Fixed- Versus Variable-Dose Prothrombin Complex Concentrate for the Emergent Reversal of Vitamin K Antagonists: A Systematic Review and Meta-Analysis.
Alwakeal A; Maas MB; Naidech AM; Jahromi BS; Potts MB
Crit Care Med; 2024 May; 52(5):811-820. PubMed ID: 38353592
[TBL] [Abstract][Full Text] [Related]
16. Safety and effectiveness of a prothrombin complex concentrate in approved and off-label indications.
Marcos-Jubilar M; García Erce JA; Martínez-Calle N; Páramo JA; Martínez Virto A; Quintana-Díaz M
Transfus Med; 2019 Aug; 29(4):268-274. PubMed ID: 31347218
[TBL] [Abstract][Full Text] [Related]
17. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.
Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE
Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788
[TBL] [Abstract][Full Text] [Related]
18. Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal: Does One Dose Fit All?
Schwebach AA; Waybright RA; Johnson TJ
Pharmacotherapy; 2019 May; 39(5):599-608. PubMed ID: 30892733
[TBL] [Abstract][Full Text] [Related]
19. The impact of the approval of prothrombin complex concentrates for vitamin K antagonist-related intracerebral hemorrhage: A retrospective study.
Watanabe S; Matsumoto S; Nakahara I; Morioka J; Hasebe A; Tanabe J; Suyama K; Ishihara T; Ohta T; Hatano T; Nagata I; Hirose Y
J Stroke Cerebrovasc Dis; 2022 Dec; 31(12):106861. PubMed ID: 36323169
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
